TEAM.NASDAQAtlassian CORP

Form 4: Atlassian Co-CEO Michael Cannon-Brookes Sells Shares Under 10b5-1 Trading Plan

Sentiment:

SEC Form 4 Filing


Michael Cannon-Brookes, Co-CEO and Co-Founder of Atlassian, sold shares of Class A Common Stock on April 10, 2024, under a pre-arranged Rule 10b5-1 trading plan.

Summary

  • Michael Cannon-Brookes, Co-CEO and Co-Founder of Atlassian, reported the sale of Class A Common Stock on April 10, 2024.
  • The sales were executed under a Rule 10b5-1 trading plan adopted on February 21, 2023.
  • A total of 8,242 shares were sold at weighted average prices ranging from $199.1012 to $205.0063.
  • The shares were sold indirectly through a trust (CBC Co Pty Limited as trustee for the Cannon-Brookes Head Trust).
  • Following the reported transactions, the number of shares held indirectly by the trust decreased to 448,860.

Sentiment

Score: 5

Explanation: The document is a standard SEC Form 4 filing, indicating routine transactions. The use of a 10b5-1 plan suggests the sales were pre-planned and not based on any specific non-public information, resulting in a neutral sentiment.

Industry Context

Sales by insiders are a common occurrence, and the use of a 10b5-1 plan suggests the sales were pre-planned and not based on any specific non-public information.

Stakeholder Impact

  • The share sales by a key executive could be perceived negatively by some shareholders, although the existence of a 10b5-1 plan mitigates this concern.

Key Dates

DateDescription
February 21, 2023Date of adoption of the Rule 10b5-1 trading plan.
April 10, 2024Date of the reported transactions (share sales).
April 11, 2024Date of signature of the Form 4 report.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.